EFPIA Proposes To Erase Japanese Vaccine Gap
This article was originally published in PharmAsia News
The Japanese unit of the European Federation of Pharmaceutical Industries and Associations, Tokyo-based EFPIA Japan, has drawn up a position paper and plans to start talks with the government on proposals to erase the vaccine gap between Japan and Europe. EFPIA Japan's paper also calls for the Japanese government to integrate its vaccine standards with the ones used by the U.S., Europe and the World Health Organization, making vaccines more easily exported and imported, and to provide necessary financial support to increase the vaccination of Japanese citizens. (Click here for more - Japanese language
You may also be interested in...
Results from two trials confirm patients at high risk of bleeding treated with Abbott’s Xience stent can be safely treated with short regimens of dual antiplatelet therapy.
Through a licensing-out deal with ORIC for its EGFR/HER2 exon-20 inhibitor, South Korea's Voronoi hopes to gain from its new partner's commercialization experience in NSCLC. The alliance hopes to build a potentially best-in-class presence in a competitive landscape.
An expert panel at the virtual HLTH conference discussed the role of robotics in improving health and wellness in the health continuum. See what Darla Hutton, vice president of US marketing and customer hospital analytics at Intuitive Surgical, said about the future of robotics.